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Highlights:
1) Synthesis of cis-[Ru(2,2'-bipyridine)2(4-benzoylpyridine)(CO)](PF6)2 
(I).
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2) Synthesis and structure of cis-[Ru(2,2'-bipyridine)2(4-
benzoylpyridine)Cl](PF6)2 (II).
2) Ultraviolet photolysis of I sequentially releases benzoylpyridine and
CO.
3) Blue light photolysis of I releases only benzoylpyridine.
4) Blue light photolysis of II can replace the 4-benzoylpyridine with 
guanine. 
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Abstract
The ruthenium(II) compounds cis-[Ru(bpy)2(4-bzpy)(CO)](PF6)2 (I) and
cis-[Ru(bpy)2(4-bzpy)(Cl)](PF6) (II) (4-bzpy = 4-benzoylpyridine, bpy =
2,2’-bipyridine) were synthesized and characterized by spectroscopic
and  electrochemical  techniques.  The  crystal  structure  of  II was
determined by X-ray diffraction. The photochemical behavior of  I in
aqueous solution shows that irradiation with ultraviolet light (365 nm)
releases  both  CO and  4-bzpy  leading  to  the  formation  of  the  cis-
[Ru(bpy)2(H2O)2]2+  ion  as  identified  by  NMR  and  electronic
spectroscopy.  Carbon  monoxide  release  was  confirmed  with  the
myoglobin  method  and  by  gas  chromatographic  analysis  of  the
headspace.  CO  release  was  not  observed  when  aqueous  I was
irradiated with blue light (453 nm). Changes in the electronic and 1H
NMR spectra indicate that  I  undergoes photoaquation of  4-bzpy  to
form  cis-[Ru(bpy)2(CO)(H2O)]2+.  Blue  light  irradiation  of  aqueous  II
released the coordinated 4-bzpy to give the  cis-[Ru(bpy)2(H2O)(Cl)]2+
ion.  When the latter reaction was carried out in the presence of the
nucleobase guanine, Ru-guanine adducts were formed, indicating that
the metal containing photoproduct may also participate in biologically
relevant reactions. The photochemical behavior of I indicates that it
can release either CO or 4-bzpy depending on the wavelength chosen,
a feature that may have therapeutic application. 
Keywords: photorelease; carbon monoxide; metallodrug; ruthenium
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Introduction
There has been considerable interest in recent years regarding
the use of photoactive metal complexes for therapeutic applications
[1,2]. In this context, the ruthenium(II)  bis(bipyridyl)  complexes are
well known for their photophysical and photochemical properties and
have been explored for biomedical and biophysical applications  [1].
Due  to  their  synthetic  versatility,  these  are  good  candidates  for
photo-activated prodrugs  [2-5] with some being subjected to clinical
and  preclinical  trials  [6].  For  examples,  Turro  and coworkers  have
explored  the  photo-uncaging  of  various  ligands  that  have  chemo-
therapeutic  activity  from such  platforms  [10-12].   Etchenique  and
coworkers  previously  reported  the  photo-controlled  release  of  a
pyridine  derivative  bound  to  a  ruthenium(II)  bis(bipyridine)  center.
This ligand was 4-aminopyridine , which is neurochemical agent that
blocks K+ channels  [7]. This lab has also prepared a series of other
metal-based  photoreleasing  systems  [8].   In  a  different  approach,
Sadler et al.  [4] have described the photochemical and nucleobase
binding properties of intermediates formed by photo-labilization of Cl–
from cis-[Ru(bpy)2(CO)Cl]+  and concluded that this strategy provides
valuable  leads  for  new  photo-activated  antitumor  ruthenium
complexes. However, Ru-Cl bond hydrolysis also occurs in the dark,
rendering that compound less-specific for photo-drug applications.
The present work was initiated to examine how changing the
ligand (L) in complexes of the type cis-[Ru(bpy)2(CO)L]+ changes the
photochemical  properties  of  these  species.  Here  we  describe  the
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synthesis, characterization and photochemical properties of the new
complex salts cis-[Ru(bpy)2(4-bzpy)(CO)](PF6)2 (I) and cis-[Ru(bpy)2(4-
bzpy)(Cl)](PF6)  (II),  where 4-bzpy = 4-benzoylpyridine,  a  -acceptor
ligand. The ligand 4-benzoylpyridine was chosen because presents a
more  extended  π -system in  comparison  to  other  pyridine  ligands
previously used in ruthenium-based NO donors, cis-[Ru(bpy)2L(NO)]n+
(L  = pyridine,  picoline,  4-acetylpyridine,  isonicotinamide)  [9,  10].  .
Additionally,  It was observed that blue light photolysis (453 nm) of
either  I or  II leads to labilization of 4-bzpy, while near-UV photolysis
(365 nm) of I also leads to CO release.
Carbon  monoxide  is  a  small  molecule  bioregulator  in
mammalian  physiology  that  may play  key roles  in  wound healing,
cytoprotection  during  inflammation  and  prevention  of
ischemia/reperfusion  injury  [11,  12].   These  properties  have
engendered  interest  in  developing  strategies  for  CO  delivery  to
physiological  targets  including   thermally  and  photochemically
activated CO-releasing moieties (CORMs, [12] and  photoCORMs [13-
15], respectively). For the latter, using light as the trigger can define
the  location,  timing  and  dosage  of  CO  release.  Although  optimal
transmission of light through mammalian tissue requires red or near
infrared wavelengths, shorter wavelength excitation may have value
in  treatment  of  subcutaneous  cancers  [16,  17] and  bacterial
infections [20]. 
The  metal  containing  product  from  photoreactions  of  a
photoCORM  may  also  be  biologically  active  and  offer  some
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therapeutic potential. One might draw inspiration from the action of
cisplatin, which crosslinks with DNA purine bases. However, cisplatin
use is dose-limited due to systemic toxicity, primarily to the kidney
[18].   An alternative strategy would be to use complexes that  are
inactive  in  the  dark  but  react  with  nucleobases  upon  irradiation
[11,12].  In  this  context,  it  is  notable the products  generated upon
photolysis of II display nucleobase binding properties.
Experimental Section
Materials:  Ultrahigh  purity  water  from  a  Millipore  system
(model:  Millipore  Direct  Q®  3UV)  was  used  throughout  the
experiments. RuCl3·xH2O, 4-benzoylpyridine and 2,2’-bipyridine were
purchased from Sigma-Aldrich and used without further purification.
cis-[Ru(bpy)2Cl2]  (III) was  prepared  according  to  a  procedure
described in the literature [19].
Synthesis of the complexes: cis-[Ru(bpy)2(4-bzpy)(Cl)](PF6).H2O
(II): A solution was prepared by mixing a sample of III (0.200 g, 0.41
mmol)  and  4-benzoylpyridine  (0.080g,  0.43  mmol)  in  a  1:1
ethanol/water solution (20 mL). This mixture was heated at reflux for
3 h. The resulting solution was concentrated by rotary evaporation to
a volume of 10 mL. The solid  II was precipitated by the addition of
saturated aqueous NH4PF6 solution (2 mL), collected by filtration and
washed with cold water.  Yield = 87 %. IR (KBr disks, max/cm-1): 3117
(C-H); 1667 (C=O, ketone group); 1446 (C-N);  1H NMR (500 MHz, d6-
acetone, δ): 8.62 (d, bzpy-H21,21’, J = 5.50 Hz); 7.61 (d, bzpy-H22,22’, J =
6
6.00Hz); 7.83 (d, bzpy-H26,26’, J = 7.00 Hz); 7.52 (t, bzpy-H27,27’, J = 7.70
Hz);  7.73  (t,  bzpy-H28,  J  =  6.90  Hz).   Analysis:  Calcd.  for
C32H27ClF6N5O2PRu.  Exp.  (calc):  C,  48.58  (48.34);  H,  3.41  (3.42);  N,
8.85  (8.81)%.   We  also  report  the  X-ray  crystal  structure  of  this
compound (see below)
cis-[Ru(bpy)2(4-bzpy)(CO)](PF6)2.H2O(I): The reaction was carried
out in a Schlenk flask connected to a CO gas line.  A sample of  cis-
[Ru(bpy)2(4-bzpy)Cl]PF6 (0.100  g,  0.14  mmol)
diluted in dimethylformamide (3.0 mL) was stirred under CO (1 atm)
at 120  oC for  120 h.  The solid was precipitated by the addition of
saturated aqueous NH4PF6 solution (2 mL), collected by filtration and
washed with cold water. Yield = 93%.   IR spectrum (KBr disk, max/cm-
1):  3117 (C-H);  1446 (C-N), 1665 (C=O,  ketone group),  1962 (CO
carbonyl  ligand);  1H NMR (500 MHz,  acetone-d6,  δ):  9.10  (d,  bzpy-
H21,21’, J = 5.50 Hz); 8.06 (d, bzpy-H22,22’, J = 6.00 Hz); 7.89 (d, bzpy-
H26,26’, J = 7.00 Hz); 7.57 (t, bzpy-H27,27’, J = 7.70 Hz); 7.76 (t, bzpy-H28,
J  =  6.90  Hz). Analysis:  Calcd.  for  C33H27F12N5O3P2Ru.  Exp.(calc):  C,
42.49 (42.50); H, 2.89 (2.92); N, 7.51 (7.51)%.
Instrumentation:  Electrochemical experiments were performed
in a BAS Epsilon 2 818 electrochemical  analyzer from Bioanalytical
Systems.  These  measurements  were  performed  using  millimolar
solutions  of  the  complexes  in  acetonitrile  as  solvent  and
tetrabutylammonium  perchlorate  (TBAP)  0.1  M  as  supporting
electrolyte. A conventional three-electrode glass cell was used with
glassy carbon (ca. 0.13 cm2 geometrical area), Pt foil,  and Ag/AgCl
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(filled with acetonitrile containing 0.1 M TBAP) working, auxiliary and
reference electrodes, respectively. The electrochemical experiments
were conducted at room temperature. 
FTIR  spectra  were  recorded  for  compounds  I and  II in  KBr
pellets  using  an  ABB  Bomem  FTLA  2000-102  spectrophotometer.
NMR  spectra  were  recorded  using  a  Bruker  AVANCE  DPX500
spectrometer in acetone-d6. Photoproducts formed upon irradiation of
I and of II in DMSO-d6/D2O (20/80, v/v) and DMSO-d6/D2O (5/95, v/v)
solutions,  respectively,  were  characterized  by  recording  their  NMR
and optical absorption spectra. Electronic spectra were recorded on a
HP-8453 diode-array spectrophotometer.
 X-ray diffraction studies of single crystals of II were carried out
on  an  Enraf–Nonius  Kappa  CCD  diffractometer,  using  Mo  K()
radiation  (0.71073  Å).  Data  collection  used  the  COLLECT  program
[20], and integration and scaling of the reflections were performed
with the HKL Denzo-Scalepack system of programs  [21]. Absorption
corrections were carried out by using the multi-scan method [22]. The
structure  was  solved by  direct  methods  with  SHELXS-97  [23].  The
models were refined by full-matrix least-squares on F2 with SHELXL-
97 [24]. All the hydrogen atoms were stereochemically positioned and
refined with the riding model.
Photolysis experiments were carried out at room temperature in
1.0  cm  path  length  quartz  cells  capped  with  rubber  septa.  The
solutions were deaerated by bubbling argon prior to photolysis and
stirred during irradiation.  Simultaneous dark reactions were carried
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out  with  identical  solutions  as  controls.  The  UV-Vis  spectra  of  the
latter solutions showed these samples to be stable in the dark at least
during the time scale of the photochemical experiments.  Quantitative
analysis  of  product  formation  and  disappearance  of  the  starting
materials  was  carried  out  by  monitoring  the  electronic  spectral
changes (see below). 
Continuous photolysis was performed using a blue LED (max =
453 nm) or with the output from a 200 W high pressure mercury lamp
mounted on an Oriel optical train passed through an interference filter
to isolate the mercury line at 365 nm. Lenses were used to collimate
the light beam and a shutter was used to control the irradiation time.
The light intensity was determined using chemical actinometry with
potassium  trisoxalatoferrate(III)  [25,  26].  In  general,  incremental
quantum yields determined from incremental spectral changes were
plotted  versus  the  percent  reaction  and  extrapolated  back  to  0%
reaction to minimize inner filter effects. A linear fit of these data over
the first 25-30% of the reaction provided a y-intercept equal to the
initial quantum yield. Each reported quantum yield is the average of,
at  least,  three  independent  experiments.  For  the  primary
photoreaction  of  compound  I, quantum yields  were determined by
plotting the incremental quantum yields for the absorbance decrease
at 415 nm versus the elapsed irradiation time as shown in Supporting
Information (SI) Figures S1 and S2, respectively. For the secondary
photoreaction of I seen with 365 nm irradiation, the spectral changes
were measured after 2 min of irradiation, when the primary reaction
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was  effectively  complete.  In  this  case,  the  quantum  yield  was
determined by plotting the incremental quantum yields after the first
2 min as calculated from further absorbance decreases at 415 nm
versus the elapsed irradiation time (SI Figure S3).  For photolysis of
compound  II,  the  quantum  yield  was  determined  by  plotting
incremental quantum yields for the decrease of a band at 440 nm
versus the elapsed irradiation time as shown in SI Figure S4.
Interaction  with  guanine:  An  NMR  sample  was  prepared  by
dissolving 8.4 mg of II in 0.035 mL of DMSO-d6. To this was added a
0.665 mL aliquot of a guanine stock solution prepared by dissolving
24.8 mg of  guanine in  5 mL of  warm D2O/NaOH (0.02 M) solution
under stirring.  The guanine stock solution was added dropwise with
stirring to avoid precipitation of the compound.  The reaction during
453 nm photolysis of the solution was followed by NMR and electronic
spectra for 2 h until the photoreaction is complete. The photoproduct
solution was then stirred for 24 h to react with guanine after which
NMR and electronic spectra were again obtained.
Analysis of CO release: The myoglobin assay [28] was used to
evaluate  photochemical  CO  release  from  cis-[Ru(bpy)2(4-bzpy)CO]
(PF6)2.  In  this  assay,  conversion  from  deoxy-myoglobin  (Mb)  to
carbonmonoxy-myoglobin (MbCO) was monitored using a Cary 5000
UV-Vis-NIR/Varian  spectrophotometer.  All  experiments  were  carried
out under anaerobic conditions using a glove box (COY laboratories).
For a typical measurement, myoglobin was dissolved in 1000 L of 0.1
M phosphate buffer (pH 7.3), resulting in a 48 M solution, placed in a
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1 cm quartz cuvette and degassed with argon. Subsequently, a 2X
excess of sodium dithionite was added to convert met-Mb to deoxy-
Mb. Due to the insolubility of  I  in  aqueous buffer,  a stock solution
(~96  M)  was  prepared  in  methanol,  and  a  aliquot  of  this  stock
solution (1000 L) plus PBS buffer were then added to the deoxy-Mb
solution to give a total volume 4000 L and  a final solution containing
I (24 M), myoglobin (12 M) and dithionite (24 M). The cuvette was
sealed with  a  plug to  prevent  escape of  CO or  reoxidation  of  the
myoglobin.  The solution was initially  kept in the dark to study the
stability of the complex in aqueous buffer and then was illuminated
using UV light (350 nm) until  no further spectral changes could be
observed for several consecutive measurements. Illuminations were
interrupted  in  regular  intervals  to  record  the  optical  absorption
spectrum. A dark control experiment was performed under the same
conditions.  This  procedure  was also  followed using blue  light  (453
nm);  however,  there was no evidence for  CO release in  the latter
case.   
GC Analysis of CO release: The experiment was carried out as
follows: A sample of  I (15 mg) in a DMSO/H2O (20/80, v/v) solution
under 1 atm of argon in a Schlenk cuvette was photolyzed for 2 h
using 365 nm light. The solution was allowed to equilibrate with the
gas phase by shaking repeatedly for 2-3 min. A 500 μL sample of the
gas phase from the Schlenk cell was then removed with a gastight
syringe and the CO content was determined by gas chromatography
with thermal conductivity detection (GC-TCD) using a programmable
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Agilent model 6890 GC with a 10 m Carbosieve packed column. The
injection port was maintained at 50 oC and the detector at 250 oC. The
carrier  gas  was helium at a flow of  7.3 mL.min-1.  The column was
maintained at 35 oC for 5 min, raised at 40 oC. min-1 to 250 oC and held
for 45 min. Carbon monoxide is well resolved with this configuration
and is detected with an elution time of ca. 8.0 min.  
Results
Syntheses  and  characterizations:  The  complex  salt  cis-
[Ru(bpy)2(4-bzpy)(Cl)](PF6)  (II)  was  prepared  and isolated  from the
reaction  of  cis-[Ru(bpy)2Cl2]  (III)  with  4-benzoyl  pyridine  and
characterized  using  NMR and  infrared  spectroscopy  and  elemental
analysis.  In addition, the X-ray crystal structure of  II  was obtained.
The IR spectra of both showed bands characteristic of the (C=N) and
(C=C) bonds for 4-bzpy and overlapping bands of the bpy ligand in
the range of 1610–1400 cm-1.  A band at 1665 cm-1 is attributed to
(C=O)  of  the  ketone  group  of  4-bzpy  that  is  absent  in  the  IR
spectrum of the precursor III (SI Figure S5). 
The structure of II was confirmed by X-ray diffraction studies of
crystals  obtained by slow evaporation  from methanol.  Crystal  data
and structure refinement for this complex are summarized in Table 1
and the ORTEP projection is  shown in the Figure 1.  Selected bond
lengths and angles are given in Table 2. The structure confirms the
assignment of cis geometry of the chloride ligand in relation to 4-bzpy
ligand suggested by the synthetic route. The Ru-N(bpy) bond lengths
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for Ru-N1 (2.052), Ru-N2 (2.064) and Ru-N3 (2.074 Å), each are trans
to a nitrogen ligand, are quite similar, while that of Ru-N4 (1.965),
trans to  a  chloride,  is  somewhat  shorter.  These  results  are  in
agreement  with  structures  determined  for  related  complexes  [27].
The presence of a single PF6- ion confirms that the ruthenium is in the
Ru(II) oxidation state. 
Complex II was further characterized by 1H NMR and 2D COSY
spectroscopy and this is analyzed in the Supporting Information  (SI
Figure  S6).  All  16  signals  for  the  H's  of  the  two  bipyridines  were
observed suggesting all H atoms are magnetically non-equivalent[28,
29], as expected for the cis-[Ru(bpy)2(4-bzpy)Cl]+ complex.
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Table 1.  Crystal data and structure refinement for cis-[Ru(bpy)2(4-
bzpy)(Cl)](PF6) (II).
Empirical formula (C32H25N5OClRu)+.PF6-
Formula weight 777.06
Crystal system Monoclinic
Space group P21/c
Temperature 293(2) K
Crystal size 0.3 x 0.2 x 0.1 mm3
Unit cell dimensions a = 11.42(4) Å
b = 21.24(6) Å = 99.8(2)°
c = 15.31(6) Å
Volume 3660(23) Å3
Z 4
Absorption coefficient 0.607 mm-1
F(000) 1560
Reflections collected 23911
Independent reflections 5819 [R(int) = 0.0973]
Goodness-of-fit on F2 1.015
Final R indices [I>2(I)] R1 = 0.0809, wR2 = 0.1755
R indices (all data) R1 = 0.2153, wR2 = 0.1945
CCDC ref number 1487399
a  Data collection, data processing, structure solution and structure 
refinement, respectively.
Figure 1. ORTEP  5 view of the complex cation of  II,  showing atom
labeling and the 50% probability ellipsoids.
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Table 2. Selected Bond lengths [Å] and angles [°] for cis-[Ru(bpy)2(4-
bzpy)(Cl)](PF6) (II).
        Bond lengths (Å)  Bond angles (o)
Ru-N4 1.965(14) N4-Ru-N1 91.2(3)
Ru-N1 2.052(9) N1-Ru-N3 95.0(4)             
Ru-N2 2.064(9) N2-Ru-N3 174.4(4)
Ru-N3 2.074(10) N2-Ru-N5 96.0(5)
Ru-N5 2.125(9) N1-Ru-N5 176.0(3)
Ru-Cl 2.408(10) N4-Ru-Cl 173.7(4)
N1-C1 1.351(10) N2-Ru-Cl 86.3(3)
N1-C5 1.355(11) N5-Ru-Cl 91.1(3)
N2-C6 1.327(11) C1-N1-C5 116.6(8)
N2-C10 1.354(10) C1-N1-Ru 128.3(8)
O1-C26 1.313(16) C25-N5-Ru 118.9(9)
C22-C23 1.326(13) O1-C26-C2) 122.5(17)
C23-C24 1.386(13) O1-C26-C23 116.8(15)
C24-C25 1.396(12) C27-C26-C23 120.5(16)
C26-C27 1.384(16) C26-C27-C28 129.1(17)
The  well-characterized  complex  II was  used  to  prepare cis-
[Ru(bpy)2(4-bzpy)(CO)](PF6)2  (I) by reaction with CO. The IR spectrum
of the isolated compound showed a strong ν(CO) band at 1962 cm -1
within  the  range  noted  for  other  Ru(II)-CO  compounds  [30,  31],
confirming the presence of  coordinated CO (SI  Figure S-7).  The IR
spectrum of  I also exhibited vibrational bands corresponding to the
(C=N)  and  (C=C)  modes  of  the  4-benzoylpyridine  ligand  with
overlapping bands of the bipyridine ligands in the range of 1610–1400
cm-1  [32] and the strong band at 1665 cm-1 attributed to the ketone
(C=O)  of  4-bzpy,  consistent  with continued  coordination  of  this
ligand after exchange of chloride for CO, as is the elemental analysis.
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Analogous bands are observed in the IR spectrum of II (SI Figure S7)
and of other 4-bzpy complexes such as fac-[Re(Cl)(4-bzpy)2(CO)3] and
fac-[Re(Cl)(4-bzpy)2(CO)3] [33]. 
The carbonyl  complex  I was further characterized by  1H NMR,
13C  NMR,  and  HMBC  (Heteronuclear  Multiple-Bond  Correlation)
spectroscopy.  Figure  2 illustrates  the  HMBC  spectrum  for  cis-
[Ru(bpy)2(4-bzpy)(CO)](PF6)2, where 1H nuclei are correlated to remote
13C nuclei (two or three bonds away) in a 2D experiment via long-
range heteronuclear J couplings (2JCH and  3JCH)  [34]. This experiment
shows CO resonances at low field ( 194.30 and  200.48 ppm). Only
the first  is  correlated with H's  in  neighboring bonds,  and this  was
assigned to the ketone carbonyl of the 4-bzpy ligand. The signal at 
200.48 ppm can be assigned to the CO ligand, whereas coordinated
carbonyls typically appear in the  13C NMR spectrum in the range of
180-250 ppm [4, 33, 35]. The cross peak between the ketone carbon
and  the  peaks  at   7.89  and   8.06  ppm observed  in  the  HMBC
experiment locates the two doublet signals of protons corresponding
to H-29/H-33 and H-23/H-25, respectively, shown in Figure 2A. The 1H
NMR spectrum showed signals for the other hydrogens present in the
4-bzpy ligand, two triplets at 7.57 and 7.76 ppm, assigned to the H-
30/H-32 and H-31, respectively. All the signals are shifted downfield
from those observed for  the  free  ligand.  This  effect  is  even more
pronounced for H-22/H-26 ( 9.10 ppm versus  8.81 in free), due to
proximity to the ruthenium center. Additionally, the 16 signals seen
for  the  bipyridine  hydrogens  indicate  that  all  H's  are  magnetically
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nonequivalent  [36,  37]  as  expected  for the  cis  configuration  this
cation.
Cyclic  voltammetry  (SI  Figure  S8)  revealed  quasi-reversible
events with E1/2(Ru2+/3+) values of –0.11, 0.55 and 1.15 V vs Ag/AgCl
(which would be the equivalent of 0.01, 0.56 and 1.34 vs Fc/Fc+) and
Ep  values  of  0.10,  0.09  and  0.11  V  for  the  respective  complex
compounds  III,  II and I.  Replacing one chloride of
cis-[Ru(bpy)2(Cl2)]  by  the-acceptor  ligand  4-bzpy  to  give  cis-
[Ru(bpy)2(4-bzpy)(Cl)]+ leads to an anodic shift of the redox potential
by 0.66 V (-0.11 vs 0.55V). Replacing the second chloride by CO to
give I leads to a further anodic shift of 0.60 V. Thus, these -acceptor
ligands (4-bzpy and CO) stabilize the ruthenium d-orbitals,  and the
Ru(II) center is much less readily oxidized. 
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Figure 2. A) Drawing of cis-[Ru(bpy)2(4-bzpy)(CO)]2+. B) HMBC spectrum of 
I in CD3COCD3.
The electronic absorption spectra of the cis-[Ru(bpy)2(4-bzpy)L]
+/2+ complexes in DMSO/H2O (20/80, v/v) solution (SI Figures S9 and
S10)  display  strong  bands  in  the  ultraviolet  region  and  somewhat
weaker bands in the visible.  For I (L = CO), these bands occur at 274
nm ( = 2.01 x 104 M-1 cm-1), 303 nm (6.93 x 103 M-1 cm-1) and 415 nm
(5.90 x 103 M-1 cm-1), while for  II (L = Cl–) analogous bands occur at
315 nm ( = 2.20 x 104 M-1 cm-1), 345 nm (7.93 x 103 M-1 cm-1) and 440
nm (1.24 x 104 M-1 cm-1).  The UV absorption spectrum of free 4-bzpy
displays a strong peak at 264 nm and a shoulder at 223 nm  [38].
Although  free  4-bzpy  has  a  relatively  low-lying  n*  excited  state
involving  a  ketone  oxygen  nonbonding  orbital  [33],  these  strong
bands are  π*π (4-bzpy) in origin.  The higher energy strong bands
observed  in  the  spectrum  for  the  cis-[Ru(bpy)2(4-bzpy)L]+/2+
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complexes are likely to be largely ligand localized transitions of the
type (π*π(bpy) , π*π (4-bzpy),  π*n(4-bzpy) although these may
overlap with  π*(bpy)dπ(Ru) metal to ligand charge transfer (MLCT)
transitions.  In  analogy  with  other  Ru(II)  complexes  [39,  40],  the
weaker visible range band seen for each complex can be assigned to
a MLCT transition.  Notably, this band occurs at higher energy for the
carbonyl complex I than for the chlorido analog II. This effect can be
attributed  to  the  π*(CO)dπ(Ru)  backbonding  interaction  that
stabilizes the dπ(Ru) orbitals in I. 
Photochemical  Studies:  The  photochemical  behavior  of  I in
DMSO/H2O (20/80, v/v) solution was found to be complex, where there
was no clear isosbestic point.  From Figure 3, it is evident that the
electronic spectra of photoproducts formed upon irradiation with blue
light (irr  = 453 nm) (dotted line) and with UV light (irr  = 365 nm)
(dashed line)  are  different.  Photolysis  with  blue  light  leads  to  the
appearance  of  a  new  absorption  band  at  ca.  450  nm  while  UV
photolysis gives a new band at 475 nm (Figure 3). Additionally, UV
irradiation exhibited faster processes, where an apparent isosbestic
point  owing   to  faster  photo-induced  4-bzpy release but  this  soon
breaks down upon CO release. Thus, the product distribution from I is
wavelength dependent. Furthermore, UV photolysis of  I  leads to CO
release as demonstrated below, while no CO release was detected by
the myoglobin test when an analogous solution was irradiated at 453
nm.  
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Figure  3.  UV-visible  spectra  of  cis-[Ru(bpy)2(4-bzpy)(CO)](PF6)2
complex (I) in 20/80 DMSO/H2O solution (6.42 x 10-5  M) as a function
of  photolysis.  Solid  line: before  irradiation.  Dotted  line:  after
irradiation  with  blue  light  (irr.  =  453  nm)  for  2  h.  Dashed  line:
spectrum  after  photolysis  of  I with  365  nm  light  for  2  h. Inset:
Progressive spectral changes during the 365 nm photolysis of I in the
same solvent over a period of 2 h (note: over time photolysis induced
changes  showed  red  shifts  in  the  visible  absorption  bands  as
benzoylpyridine  and CO are sequentially liberated.) 
The temporal  spectral  changes  upon  photolysis  of  aqueous  I
with a blue LED showed a decrease in the MLCT absorption at 415
nm,  the  appearance  of  the  new  band  at  max 450  nm  with  an
isosbestic point at c.a. 450 nm (SI Figure S11) over the first 15 min,
which  supported  initial  release  of  4-bzpy.  Further  photolysis  for
another 105 min led to no further changes. The absence of CO as a
product  and  the  general  unreactivity  of  the  bpy  ligands  toward
photolabilization  suggests that  the  visible  light  stimulated
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photoreaction  gives  the  monaqua  species  cis-[Ru(bpy)2(CO)(H2O)]2+
(eq 1). The quantum yield bzpy  for this reaction was determined from
the spectral changes to be 0.075  0.003 (SI Figure S1).
The 365  nm  irradiation  of  aqueous  I displayed  a  different
pattern of spectral changes. In the initial stage, the MLCT absorption
at  415  nm decreases  and  the  band  at  450  nm becomes  evident
(Figure 3, inset) within 2 min of irradiation, similar to the pattern seen
for  the  longer  wavelength  photolysis.  This  behavior  suggests  the
formation of  cis-[Ru(bpy)2(CO)(H2O)]2+ as an intermediate.  However,
continued  365  nm  photolysis  is  accompanied  by  evolution  of  the
spectrum to give a new band with  λmax at 475 nm (Figure 3, inset,
dashed line). The peak at 475 nm agrees with the spectrum of the
diaqua complex cis-[Ru(bpy)2(H2O)2]2+  (IV)  [41]. Thus, it appears that
the  intermediate  aquo  carbonyl  complex  undergoes  secondary
photolabilization of CO under continued UV photolysis (eq. 2).  Under
these conditions the quantum yield for the primary photoreaction was
determined  to  be  0.0950.003  (SI  Figure  S2),  while  that  for  the
secondary reaction was determined to be  CO =  0.041   0.004 (SI
Figure S3).
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It  should  be  noted  that  no  spectral  changes  were  observed
when the solution of I was kept in the dark under similar experimental
conditions. Alternatively, when the solution was photolyzed with blue
light to give the spectrum of the intermediate -[Ru(bpy)2(CO)(H2O)]2+
(V), there was no further spectral change upon storing for 24 h in the
dark. This indicates that a second high energy photon is necessary for
CO labilization from V . 
With the aim of better characterizing the photoproducts, the 1H
NMR spectra of  I in DMSO-d6/D2O (20/80, v/v) were recorded before
irradiation (Figure 4A), after irradiation with blue light (Figure 4B) and
after irradiation with UV light (irr = 350 nm) (Figure 4C). The aromatic
region in the 1H NMR spectrum before irradiation (Figure 4A) shows all
the resonances from the non-equivalent sixteen protons of the two
bpy ligands and five signals from the protons of the 4-bzpy ligand (
7.1-8.5)  (SI Figure S12). Based on analogy to the 1H NMR spectra of
[Os(bpy)2(CO)(X)]+ (X = Cl, CF3SO3 or H) [42] and cis-[Ru(bpy)2(CO)Cl]
+[4] the two lowest-field doublets ( 9.31 and  9.22), can be assigned
to the ortho-protons of the (bpy)pyridine rings trans each other. After
irradiation with blue light (Figure 4B) the lowest-field doublet ( 9.31)
is  shifted  downfield  to   9.45  and  the  second  doublet  ( 9.22)  is
shifted upfield to  8.91. Analogous changes were observed by Sadler
et al. [4] when cis-[Ru(bpy)2(CO)Cl]+ was irradiated with white light in
DMSO-d6/D2O (5/95, v/v) to give cis-[Ru(bpy)2(CO)(D2O]2+. The 1H NMR
spectra of the blue light photoproduct from I is consistent with that of
the latter species plus that
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Figure 4. 1HNMR spectrum of cis-[Ru(bpy)2(4-bzpy)(CO)]2+ in DMSO-d6/D2O
(20/80, v/v) solution.    A: before irradiation. B: after 2 h irradiation with blue
light (irr = 453 nm). C: after 2 h irradiation with UV light (irr  = 365 nm).
of free 4-bzpy, which displays 5 resonances in the aromatic region,
the most distinctive being at   8.65  (SI Figure S12). Thus the NMR
spectra confirm that the principal photoreaction is 4-bzpy labilization
according to eq. 1.
Figure 4C shows the 1H NMR spectra of a solution of I after 2 h
irradiation with UV light (irr = 365 nm). This is clearly different to that
shown in the Figure 4B for the photoproducts from irradiation with
blue light. Comparing the 1H NMR spectrum in Figure 4C with that of
an  authentic  sample  of  cis-[Ru(bpy)2(4-bzpy)H2O]2+(VI),  which  was
prepared by reaction of cis-[Ru(bpy)2(4-bzpy)NO]3+ with NaN3[43, 44]
(SI Figure S13),  shows that VI is not the photoproduct.  Thus, since
longer term UV irradiation of I leads to CO release, with no evidence
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for formation of VI, we conclude both CO and 4-bzpy are released to
form cis-[Ru(bpy)2(H2O)2]2+ according to eq. 2. 
The release of CO as a photoproduct was confirmed using the
myoglobin (Mb) assay method.  Figure 5 shows the evolution of the
spectrophotometric  features  of  12  µM  of  reduced  MbFe(II)  in  PBS
solution  upon  addition  of  24  µM  solution  of  the  complex  cis-
[Ru(bpy)2(4-bzpy)(CO)](PF6)2 dissolved in methanol,  followed by 350
nm irradiation  of  the  solution.  MbFe(II)  was  freshly  obtained  from
native MbFe(III)  upon addition  of  excess  sodium dithionite  (24  µM)
inside an anaerobic chamber. Compound I proved to be stable in the
dark for 24 h, but it released CO upon illumination at 350 nm. Upon
irradiation for 2 h, the Q band at 557 nm related to MbFe(II) slowly
disappeared,  while  bands  at  540  and  577  nm  characteristic  of
MbFeCO appeared  [45]..  The Soret band at 435 nm also showed the
expected blue shift to 424 nm. 
Figure 5. UV-visible spectra of freshly reduced 12 µM MbFe(II) in phosphate
buffer solution upon addition of cis-[Ru(bpy)2(4-bzpy)(CO)](PF6)2 complex 24
24
µM, dissolved in methanol and irradiation with UV light (irr = 350nm). Insert:
Expansion in the region around Q bands (540 and 577 nm)1
In an independent experiment, the headspace over a solution of I was
analyzed   by  GC-TCD  after  365  nm  irradiation,  confirming  the
generation of free CO  (SI Figure S14). In contrast, there was no CO
detected in  the Schlenk cuvette headspace after  irradiation  of  cis-
[Ru(bpy)2(4-bzpy)(CO)]2+ at  453 nm. Quantification was achieved by
comparison to a calibration curve determined for CO gas. The Schlenk
cuvette has an internal volume of 30 mL and contained 4.0 mL of the
photolysis solution. Given that CO has a solubility of 0.92 mM/atm in
aqueous  solution  at  25  oC  [47] (the  temperature  used  in  these
experiments), one can calculate a partition coefficient of ~45/1 for CO
between the gas and liquid phases at equilibrium. The product of the
partition coefficient times the ratio of gas and liquid volumes (26/4)
indicates that, at equilibrium, more than 99.5% of the CO generated
will be in the gas phase of the Schlenk cuvette. The total CO released
was calculated by taking into account this partitioning. Thus, by the
GC methods, it was determined that a sample (15 mg) of I in DMSO/
1 Fairlamb and co-workers [46] A.J. Atkin;, J.M. Lynam;, B.E. Moulton;, P. Sawle;, R. 
Motterlini;, N.M. Boyle;, M.T. Pryce;, I.J. Fairlamb, Dalton Transactions 40 (2011) 
5755-5761. proposed that the myoglobin assay can be used to determine the 
amount of CO liberated from CO-RMs, but certain factors such as turbidity caused 
by poor CO-RM solubility or CO-RM absorbance, affect accurate calculation of Mb-CO
concentrations. To overcome this problem, Motterlini and co-workers[45] R. 
Motterlini, J.E. Clark, R. Foresti, P. Sarathchandra, B.E. Mann, C.J. Green, Circ. Res. 
90 (2002) 17-24. introduced the use of the isosbestic points at 510 nm as an 
internal reference for interconverting species (deoxy-MbMb-CO). However, in the 
present case, it was not possible to observe the isosbestic points, possibly because 
the electronic spectrum of the cis-[Ru(bpy)2(H2O)2]2+ product shows a band in the 
same region (figure 3, dashed line). The overlapping bands makes the method 
ineffective for quantification of released CO.
25
H2O (20/80,  v/v)  solution  photolyzed  for  2  h  at  365  nm released
0.82±0.05 equivalents of CO per mole of complex. 
Photolysis  experiments  were also performed with complex  II.
Electronic  spectra  changes during  the  photolysis  with  blue  light in
DMSO/H2O  (5/95,  v/v)  solution  showed  a  decrease  in  the  MLCT
absorption at 440 nm and formation of a new band with a max at 475
nm  within  10  min  (Figure  6). Further  changes  in  the  electronic
spectrum were not observed even after 110 min additional photolysis
or for a sample photolyzed for 30 min with blue light then stored in
the dark for 24 h. In addition, there were no spectral changes for a
DMSO/H2O (5/95, v/v) solution of  II kept in the dark under otherwise
similar experimental conditions. 
The photoreaction was also monitored by 1H NMR spectroscopy
(Figure 7). The  1H NMR spectra of the photoproduct from blue light
photolysis  of  II (Figure  7B)  is  not  the  same  as  that  for  the  cis-
[Ru(bpy)2(H2O)2]2+ (Figure 4C).  Thus, the  8.65 signal indicates that
the 4-bzpy ligand undergoes labilization to give the aqua species cis-
[Ru(bpy)2(H2O)Cl]+ (eq. 3), since this signal is observed in the 1H NMR
spectra for the free ligand 4-bzpy (SI Figure S12). 
Quantitative  evaluation  of  photo-induced  changes  in  the
absorption  spectrum  gave  the  quantum  yield  for  4-bzpy
photodissociation from II bzpy = 0.1310.005 (SI Figure S4.
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When a solution of  II  in  DMSO/H2O (5/95,  v/v)  was irradiated
with 453 nm light  in presence of 2 equivalents of guanine (G), the
spectral changes were somewhat different.  An initial decrease in the
MLCT absorption of II at 440 nm was accompanied by the growth of a
band at 475 nm over the first 30 min, consistent with formation of cis-
[Ru(bpy)2(H2O)Cl]+ (eq. 3).  When the resulting solution is left in the
dark for 24 h with stirring, the MLCT absorption at 475 nm decreased
and a new absorption  appeared at 510 nm (Figure 6-dashed line).
This  result  suggests  that  the  cis-[Ru(bpy)2(H2O)Cl]+ photoproduct
reacts  with  G  to  give  the  cis-[Ru(bpy)2(G)(Cl)]+,  (eq.  4), although
excess guanine was used in this experiment, we believe that only the
mono adduct was formed.  Earlier studies by Reedijk and co-workers
showed that cis-[Ru(bpy)2Cl2] forms only a N(7) mono adduct with 9-
ethylguanine even under strong conditions and precipitation of the
halides [[48]. 
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Figure 6.  Solid line:  Absorption spectra changes accompanying photolysis
of II (1.18 x 10-4 M), in DMSO/H2O (5/95, v/v) solution for 2 h, irr = 453 nm.
Dashed line: UV-vis spectra of II (1.18 x 10-4 M) after 453 nm irradiation in
presence of 2 equivalents of guanine (G) in DMSO/H2O (5/95, v/v) solution
followed by leaving in the dark for 24 h with stirring.
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Figure 7 shows the 1H NMR spectra obtained for a solution of II
in  DMSO-d6/D2O  (5/95,  v/v)  containing  2  equivalents  of  guanine
before photolysis and after the solution was irradiated and left in the
dark for 24 h.  Only one type of metal-nucleobase was observed as
revealed by appearance of a new singlet resonance at 6.41 ppm. This
resonance  can  be  assigned  to  the  H8 of  guanine  in  the  N(7)  Ru-
guanine mono adduct, compared to free guanine which shows this at
7.40 ppm. This shift is consistent with the shielding effect induced by
the ring current of the bpy ligands [13,[48]. 
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Figure  7.  1H NMR spectrum of  cis-[Ru(bpy)2(4-bzpy)(Cl)](PF6)  in  solution
DMSO-d6/D2O (5/95, v/v). A: before irradiation; B: after irradiation with blue
light for 2 h; C: in presence of 2 equivalents of guanine (G) in the dark; D: in
presence of 2 equivalents of guanine (G), after irradiation with blue light for
2 h and then left in the dark for 24 h under stirring. The asterisk (*) indicates
H8  proton  of  free  guanine  and  (*G)  indicates  H8  proton  of  guanine
coordinated
Summary and Conclusions
We have prepared a CO-bound ruthenium complex I containing
4-benzoylpyridine aiming to controlled photorelease CO and also to
generate  potentially  reactive  ruthenium  products.  Interestingly,
complex  I quantitatively  photoreleases  CO  upon  UV  (365  nm)
irradiation, but not upon blue light (453 nm) irradiation. However, the
4-bzpy was photoreleased at either excitation wavelength. Complex
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II, which does not contain CO was also able to photorelease 4-bzpy.
Indeed, guanine was showed to bind to the ruthenium aquo species
cis-[Ru(bpy)2(H2O)Cl]+ generated  by  the  latter  photoreaction,
suggesting that these complexes might  interact with DNA, thereby
mimicking  a  platinum-based  drug.  Along  these  lines,  such  dual  or
single  ligand  photorelease  under  controlled  wavelengths  might  be
further explored for therapeutic purposes.
  
Acknowledgments
The authors are thankful to Brazilian agencies CAPES, CNPq (L. G. F.
Lopes  303732/2014-8;  E.  H.  S.  Sousa  312030/2015-0),  FUNCAP
(PPSUS 12535691-9)  for  financial  support.   We thank Zhi  Li  of  UC
Santa Barbara for  his  help  with  quantum yield  measurements  and
with CO quantification.  
Supporting Information:  Figures S1 to S14.
References
[1] J.R. Lakowicz, Principles of Fluorescence Spectroscopy, Kluwer 
Accademic/Plenum Publishers,New York, 1999.
[2] T.S. Kamatchi, N. Chitrapriya, S.K. Kim, F.R. Fronczek, K. 
Natarajan, European Journal of Medicinal Chemistry 59 (2013) 253-
264.
[3] C. Mari, V. Pierroz, S. Ferrarib, G. Gasser, Chemical Science 6 
(2015) 2660-2686.
30
[4] L. Salassa, T. Ruiu, C. Garino, A.M. Pizarro, F. Bardelli, D. Gionolio, 
A. Westendorf, P.J. Bednarski, C. Lamberti, R. Gobetto, P.J. Sadler, 
Organometallics 29 (2010) 6703-6710.
[5] L. Salassa, E. Borfecchia, T. Ruiu, C. Garino, D. Gianolio, R. 
Gobetto, P.J. Sadler, M. Cammarata, M. Wulff, C. Lamberti, Inorganic 
Chemistry 49 (2010) 11240–11248.
[6] W. H. Ang, P.J. Dyson, European Journal of Inorganic Chemistry 
(2006) 4003-4018.
[7] L. Zayat, C. Calero, P. Albores, L. Baraldo, R. Etchenique, J Am 
Chem Soc 125 (2003) 882-883.
[8] L. Zayat, O. Filevich, L.M. Baraldo, R. Etchenique, Philos Trans A 
Math Phys Eng Sci 371 (2013) 20120330.
[9] M.G. Sauaia, F.D. Oliveira, A.C. Tedesco, R.S. da Silva, Inorganica 
Chimica Acta 355 (2003) 191-196.
[10] F.O.N. Silva, S.X.B. Araujo, A.K.M. Holanda, E. Meyer, F.A.M. 
Sales, H.C.N. Diogenes, I.M.M. Carvalho, I.S. Moreira, L.G.F. Lopes, 
European Journal of Inorganic Chemistry (2006) 2020-2026.
[11] T. Sjöstrand, Nature Reviews Drug Discovery 164 (1949) 580-
581.
[12] R. Motterlini, L.E. Otterbein, Nature Reviews Drug Discovery 9 
(2010) 728-743.
[13] R. D. Rimmer, H. Richter, P.C. Ford, Inorganic Chemistry 49 
(2010) 1180-1185.
[14] R.D. Rimmer, A.E. Pierri, P.C. Ford, Coordination Chemistry 
Reviews 256 (2012) 1509-1519.
31
[15] U. Schatzschneider, British Journal of Pharmacology 172 (2015) 
1638-1650.
[16] A. Radu, R. Conde, C. Fontolliet, G. Wagnieres, H.V. den Bergh, P.
Monnier, Gastrointestinal Endoscopy 57 (2003) 897-905.
[17] L. Brancaleon, H. Moseley, Lasers in Medical Science 17 (2002) 
173-186.
[18] M.H. Hanigan, P. Devarajan, Cancer Ther. 1 (2003) 47-61.
[19] B.P. Sullivan, D.J. Salmon, T.J. Meyer, Inorganic Chemistry 17 
(1978) 3334-3341.
[20] Enraf-Nonius, COLLECT, Delft (1997-2000).
[21] Z. Otwinowski, W. Minor, Meth. Enzymol. 276 (1997) 307.
[22] R.H. Blessing, Acta Crystallographica Section A 51 (1995) 33-38.
[23] G.M. Sheldrick, Acta Crystallographica Section A 64 (2008) 112-
122.
[24] G.M. Sheldrick, SHELXL-97., Program for Crystal Structures 
Analysis, University of Gottingen, Gottingen, Germany (1997).
[25] J.G. Calvert, J.N. Pitts, Photochemistry, J.Wiley and Sons,New 
York, 1967.
[26] G.A. Crosby, J.N. Demas, J. Phys. Chem. 75 (1971) 991-1024.
[27] D.A. Freedman, S. Kruger, C. Roosa, C. Wymer, Inorganic 
Chemistry 45 (2006) 9558-9568.
[28] R. Llanguri, J.J. Morris, W.C. Stanley, E.T. Bell-Loncella, M. Turner, 
W.J. Boyko, C.A. Bessel, Inorganica Chimica Acta 315 (2001) 53-65.
[29] M. Brissard, O. Convert, M. Gruselle, C. Guyard-Duhayon, R. 
Thouvenot, Inorganic Chemistry 42 (2003) 1378-1385.
32
[30] H. Ishida, K. Tanaka, M. Morimoto, T. Tanaka, Organometallics 5 
(1986) 724-730.
[31] E. Fujita, Coord Chem Rev. 185-186 (1999) 373-384.
[32] N.C. Yumata, G. Habarurema, J. Mukiza, T.I.A. Gerber, E. Hosten, 
F. Taherkhani, M. Nahali, Polyhedron 62 (2013) 89-103.
[33] M. Busby, P. Matousek, M. Towrie, I.P. Clark, M. Motevalli, F. 
Hartl, A. Vlček Jr., Inorganic Chemistry 43 (2004) 4523-4530.
[34] D.L. Paiva, G.M. Lampman, G.S. Kriz, J.R. Vyvyan, Introduction to 
Spectroscopy, Cengage Learning,2009.
[35] T.R. Johnson, B.E. Mann, I.P. Teasdale, H. Adams, R. Foresti, C.J. 
Greenb, R. Motterlini, Dalton Transactions (2007) 1500-1508.
[36] R. Llanguri, J.J. Morris, W.C. Stanley, E.T. Bell-Loncella, M. Turner, 
W.J. Boyko, C.A. Bessel, Inorg. Chim. Acta 315 (2001) 53-65.
[37] M. Brissard, O. Convert, M. Gruselle, C. Guyard-Duhayon, R. 
Thouvenot, Inorganic Chemistry 42 (2003) 1378-1385.
[38] Y. Bai, G.S. Zheng, D.B. Dang, Y.N. Zheng, P.T. Ma, Spectrochim 
Acta A Mol Biomol Spectrosc. 79 (2011) 1338-1344.
[39] B. Durham, S.R. Wilson, D.J. Hodgson, T.J. Meyer, Journal of 
American Chemical Society 102 (1980) 600-607.
[40] D.M. Klassen, G.A. Crosby, J. Chem. Phys. 48 (1968) 1853-1858.
[41] B. Durham, S.R. Wilson, D.J. Hodgson, T.J. Meyer, Journal 
American Chemical Society 102 (1980) 600-607.
[42] R. Gobetto, C. Nervi, B. Romanin, L. Salassa, M. Milanesio, G. 
Croce, Organometallics 22 (2003) 4012-4019.
33
[43] D.W. Raichart, H. Taube, Inorganic Chemistry 11 (1972) 999-
1002.
[44] T.J. Meyer, F.J. Miller, Journal American Chemical Society 93 
(1971) 1294-1294.
[45] R. Motterlini, J.E. Clark, R. Foresti, P. Sarathchandra, B.E. Mann, 
C.J. Green, Circ. Res. 90 (2002) 17-24.
[46] A.J. Atkin;, J.M. Lynam;, B.E. Moulton;, P. Sawle;, R. Motterlini;, 
N.M. Boyle;, M.T. Pryce;, I.J. Fairlamb, Dalton Transactions 40 (2011) 
5755-5761.
[47] R. Bartino, Iupac Solubility Data Series; Cargill, R. W., Oxford, U. 
K., 1990.
[48] P.M. van Wet, J.G. Haasnoot, J. Reedijk, Inorganic Chemistry 33 
(1994) 1934-1939.
34
